Načítá se...
Dyskinesias Do Not Develop after Chronic Intermittent Levodopa Therapy in Clinically Hemiparkinsonian Rhesus Monkeys
The stable 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced hemiparkinsonian (HP) rhesus monkey model of Parkinson’s disease (PD) has been frequently used to test preclinical experimental therapeutics targeted to treat patients with advanced PD who suffer from motor fluctuations and drug-...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2010
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3053121/ https://ncbi.nlm.nih.gov/pubmed/21074478 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.parkreldis.2010.10.010 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|